skip to main
|
skip to sidebar
Biotechnology
Home
Home
Home
Business
Internet
Market
Stock
Downloads
Dvd
Games
Software
Office
Parent Category
Child Category 1
Sub Child Category 1
Sub Child Category 2
Sub Child Category 3
Child Category 2
Child Category 3
Child Category 4
Featured
Health
Childcare
Doctors
music
politics
Uncategorized
DCA "The Cure" for Cancer?
2:34 AM
kotesh
DCA is an odourless, colourless, inexpensive, relatively non-toxic, small molecule. And researchers at the University of Alberta believe it may soon be used as an effective treatment for many forms of cancer.
Newer Post
Older Post
Home
Subscribe to Our RSS feed!
Follow Us on Twitter!
Blog Archive
►
2011
(86)
►
April
(26)
►
March
(27)
►
February
(8)
►
January
(25)
▼
2010
(50)
►
November
(25)
▼
October
(25)
Vertex Pharmaceutical's (VRTX) Telaprivir is effec...
Altus Pharmaceuticals (ALTU) is showing clinical a...
February Performance Update and reflections on pas...
Onyx Pharmaceutical's (ONXX) success may pave the ...
Gene's mutations found to cause life-threatening a...
New Poll Feature on Biotechnology Stock Blog
Drug Patent Expirations in October 2010
The Next Ambien?
Decoupled moves in Biotech indices highlight oppor...
Multi-species genome comparison sheds new light on...
Genetic Regulator Of Lifespan Identified
Curing HIV in Germany?
DCA "The Cure" for Cancer?
MicroRNAs may be key to HIV's ability to hide, eva...
Pill makes women pick bad mates
Genetic Test Predicts Response to Warfarin
Patient in Experimental Gene Therapy Study Dies, F...
CDC seeing more regular flu cases now
Multi-species genome comparison sheds new light on...
California expands newborn test for genetic abnorm...
Statin report: Could degrade adults brains
Researchers Create First Targeted Knockout Rats Us...
The Biologic Revolution
Incentives for the Biotechnology Industry
Biotechnology, An Instrument of Wealth Creation
Powered by
Blogger
.
Home
Home
Powered by
Blogger
|
Printable Coupons